PENTAX Medical DISCOVERY™ (CAN)

See how it works

NEXT LEVEL INTELLIGENCE

Watch Video

Fight colorectal cancer with artificial intelligence

Download Brochure

There is nothing like seeing PENTAX Medical DISCOVERY™ at work for yourself. We offer you various ways to get this personal experience as close up as you wish.

Experience it for yourself and see how it works

Register your free attendance to Sept 2, 2pm CEST, Live Academy “DISCOVER Colonoscopy, Improve Quality metrics: Interval cancer” with Mr. Haji from Kings College, London, UK

Registration for Symposium now!

Register your free attendance to Sept 9, 7pm CEST, ESGE Symposium DISCOVERY Satellite Symposium, Digital round table discussion via ESGE platform. “Artificial Intelligence – How to unleash the potential for colorectal polyp detection.”

Request a Live Demonstration

Let‘s set up a live demonstration in your facility, with you and your staff. Supported by a PENTAX medical specialist showing you every detail.

On-site Demonstration

Request a Live Case Attendance

Attend a real examination in an institute that already uses PENTAX Medical DISCOVERY™. We‘ll find an opportunity near you and accompany you.

OBSERVATION

PENTAX Medical DISCOVERY™ assists endoscopists in finding potential polyps during a colonoscopy examination. It is designed to detect even the most subtle lesions. Multiple factors are considered to have a negative impact on the detection rate, one of them being the human factor.

PENTAX Medical DISCOVERY™ offers you major benefits

GET HIGHLY FOCUSED ASSISTANCE In your exams

Colorectal cancer prevention is the primary goal of screening and diagnostic colonoscopy. At least 50%¹ of all interval carcinomas (iCRCs; defined as a cancer diagnosed between screening and post-screening surveillance colonoscopies) arise from missed lesions during colonoscopy. PENTAX Medical DISCOVERY™ has a high potential to contribute in decreasing the appearance of (interval) colorectal cancer by assisting endoscopists in finding potential polyps during a colonoscopy examination.

INCREASE CONFIDENCE IN THE EXAMINATION OUTCOME

The per case cost of colorectal cancer in Canada ranges from $20,319 to $39,182². PENTAX Medical DISCOVERY™ could potentially contribute to improving health care cost-efficiency.

improve health care COST-EFFiciencY

• • •

Expert curated database with thousands of images

PENTAX Medical DISCOVERY™ learned from a database of images including the most difficult lesions. This database contains thousands of dedicated images of each kind of polyp, annotated by renowned colorectal cancer centers worldwide. With this database, PENTAX Medical DISCOVERY™ assists endoscopists in finding potential polyps during a colonoscopy examination. The database of PENTAX Medical DISCOVERY™ is what sets it truly apart from any other solution in the market. The training of the Artificial Intelligence was based on a vast amount of expertly curated images.

Find out more

Imagine a world where every single detail is designed to save lives. Where everyone works for patient’s health and comfort as well as for the benefit of clinical institutions. With cleverly engineered technology and dedicated services to support your fight against disease, cancer and infections. Where you will always find smart and sophisticated answers to your daily challenges. This is the world of PENTAX Medical.

WELCOME TO THE WORLD OF INTELLIGENCE

PENTAX Medical US Website

PENTAX Medical CA

PENTAX Medical Website

PENTAX Canadian Head Office 6715 Millcreek Drive, Unit 1 Mississauga, ON L5N 5V2

T: +1 800 750 5558 F: +1 905 286 5571 E:

PENTAX Medical Website

Cookie Policy

customercare@pentaxmedical.com

1) Hannes Seibt, Albert Beyer, Michael Häfner, Christian Eggert, Harald Huber, Timo Rath: Evaluation of a real time artificial intelligence system using a deep neural network for polyp detection and localization in the lower gastrointestinal tract; Nov 2019 DDW

PENTAX Medical DISCOVERY™ Highly focused assistance to find more polyps than ever¹

Prof Timo Rath, Professor of Endoscopy and Molecular Imaging, University of Erlangen, Nuremberg, Germany

I‘m very confident that PENTAX Medical DISCOVERY™ will translate into increasing our Adenoma Detection Rate and therewith contribute to reducing colorectal cancer mortality.

“

If you have any questions or would like to learn more about PENTAX Medical DISCOVERY™, please contact us. Our product and service experts are ready to help.

Dr Sergey Kashin, Head of Endoscopy Department, Yaroslavl Regional Cancer Hospital, Russia

The PENTAX Medical DISCOVERY™ uses advanced artificial intelligence to highlight the presence of pre-cancerous lesions with a visual marker in real-time – serving as an ever vigilant second observer.

“

Prof Peter Siersema, Professor of Endoscopic Gastrointestinal Oncology, Editor-in-Chief, Endoscopy, Radboud University, Netherlands

Computer-aided detection has been shown to increase the detection of pre-cancerous colorectal lesions. The introduction of the PENTAX Medical DISCOVERY™artificial intelligence system opens the door to a new era where endoscopists and PENTAX Medical DISCOVERY™ jointly reduce health-care costs by decreasing the prevalence of colorectal cancer.

“

Major benefits

In our fight against colorectal cancer we have already achieved a lot. However, up to 26%¹ of lesions are still missed in examinations. That’s why we’re committed to developing new solutions to overcome daily challenges in colonoscopy procedures.

26%

Through digital and optical image enhancement we were able to increase adenoma detection rates (ADR) by up to 11%².

VISIBILITY

By using enhancement technology, such as RetroView™, the ADR could increase up to 24.9%³.

BLIND SPOTS

The human factor remains a challenge within colonoscopy. Now PENTAX Medical DISCOVERY™ will help you solve this, as well.

HUMAN FACTOR

ADR increase

24.9

DISCOVERY™ is an innovative device working with Artificial Intelligence. It is able to support you in the detection of unremarkable lesions and directs your attention to potential lesions. It does this in real-time, visually and with sound signals.

PENTAX Medical DISCOVERY™ is an innovative device working with Artificial Intelligence. It is intended to assist you in finding potential polyps during a colonoscopy examination.

PENTAX Medical EMEA

PENTAX Medical US Website

Major benefits

Experts opinion

Managing Director: Rainer Burkard Commercial Register / Reg. No: Commercial Register Hamburg / HRB 20 285 VAT Identification No: DE118587668

Experts opinion

¹ According to studies miss rates for polyps of any size are approximately 22 – 26%, and an AMR (adenoma miss rate) of 27% for serrated polyps. Missed lesions may have the possibility to develop into cancer. ² Bowman EA, Pfau PR, Mitra A, et al. High Definition Colonoscopy Combined with i-SCAN Imaging Technology Is Superior in the Detection of Adenomas and Advanced Lesions Compared to High Definition Colonoscopy Alone. Diagn Ther Endosc. 2015;2015:167406. doi:10.1155/2015/167406 ³ Robles-Medranda, C. et al; Safety, Feasibility, and Efficacy of Pancolonic Retroflexed Viewing Using a Short-turn Radius Colonoscope Journal of Clinical Gastroenterology 2019:00:000-000. DOI:10.1097/ MCG.0000000000001230

See how it works

3) According to studies miss rates for polyps of any size are approximately 22 – 26%, and an AMR (adenoma miss rate) of 27% for serrated polyps. Missed lesions may have the possibility to develop into cancer.

1) Bowman EA, Pfau PR, Mitra A, et al. High Definition Colonoscopy Combined with i-SCAN Imaging Technology Is Superior in the Detection of Adenomas and Advanced Lesions Compared to High Definition Colonoscopy Alone. Diagn Ther Endosc. 2015;2015:167406. doi:10.1155/2015/167406

2) Shirin H, Shpak B, Epshtein J, et al. G-EYE colonoscopy is superior to standard colonoscopy for increasing adenoma detection rate: an international randomized controlled trial. Gastrointest Endosc. 2018

Request a Live Case Attendance

Attend a real examination in an institute that already uses PENTAX Medical DISCOVERY™. We‘ll find an opportunity near you and accompany you.

OBSERVATION

Request a Live Demonstration

Let‘s set up a live demonstration in your facility, with you and your staff. Supported by a PENTAX medical specialist showing you every detail.

On-site Demonstration

Register your free attendance to Sept 21, 1pm CEST, ESGE Connect “The potential of Artificial Intelligence to fight colorectal cancer.” Broadcast from ESGE Connect via ESGE platform.

¹ Pohl H, Robertson DJ. Colorectal cancers detected after colonoscopy frequently result from missed lesions. Clin Gastroenterol Hepatol 2010;8:858-64.

² Jean Maroun 1, Edward Ng, Jean-Marie Berthelot, Christel Le Petit, Simone Dahrouge, William M Flanagan, Hugh Walker, William K Evans Lifetime costs of colon and rectal cancer management in Canada https://pubmed.ncbi.nlm.nih.gov/14733758/

Detection challenges

2) Pohl H, Robertson DJ. Colorectal cancers detected after colonoscopy frequently result from missed lesions. Clin Gastroenterol Hepatol 2010;8:858-64.

3) Corley DA, Jenson CD, Marks AR JR, et al. Adenoma Detection Rate and Risk of Colorectal Cancer and Death. NEJM 2014;370:1298-306.

4) Ulrike Haug, Susanne Engel, Frank Verheyen, Roland Linder; Estimating Colorectal Cancer Treatment Costs: A Pragmatic Approach Exemplified by Health Insurance Data from Germany

Detection challenges

¹ Hannes Seibt, Albert Beyer, Michael Häfner, Christian Eggert, Harald Huber, Timo Rath: Evaluation of a real time artificial intelligence system using a deep neural network for polyp detection and localization in the lower gastrointestinal tract; Nov 2019 DDW

* Powered by SMART Medical Systems Ltd. (Manufacturer), 5 HaNofar St., Ra’anana 4366404, Israel & MedNet GmbH (EC-REP), Borkstrasse 10, 48163 Münster, Germany

* Powered by SMART Medical Systems Ltd. (Manufacturer), 5 HaNofar St., Ra’anana 4366404, Israel & MedNet GmbH (EC-REP), Borkenstrasse 10, 48163 Münster, Germany

Register your free attendance to Dec 16, 2pm CET, Live Academy “Why human factor is important for ADR and how to improve it” with Prof. Cristiano Spada and Dr.ssa Paola Cesaro, Fondazione Poliambulanza of Brescia, Italy

PENTAX Medical Canada